Abattis Bioceuticals Corp. (ATTBF)

[GreenBrickRoad]

It's both positive and negative, because the acquisition comes with a cost.. more dilution, another 30 million shares and Abattis has really been pouring a lot of water lately. Adding the PP's, this puts us well over 300 million shares. It looks like we're heading from 180 to 400 million shares in about a year.. which is concerning.

I'm sure Abattis feels the need to act now, corner the market, solidify their diversification strategies.. I get it, but at some point, they need to unplug the printing press.. or investors are going to scatter.